High MBOAT2 expression correlates with a worse prognosis in several cancers, including PC, adrenocortical carcinoma, mesothelioma, uveal melanoma, and urothelial carcinoma, yet it is associated with longer survival in kidney renal clear cell carcinoma. The gene discussed is MBOAT2; the disease is adrenal cortex carcinoma.